Cargando…
Lung cancer: a new frontier for microbiome research and clinical translation
The lung microbiome has been shown to reflect a range of pulmonary diseases—for example: asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis. Studies have now begun to show microbiological changes in the lung that correlate with lung cancer (LC) which could provide new insights...
Autores principales: | Mur, Luis AJ, Huws, Sharon A, Cameron, Simon JS, Lewis, Paul D, Lewis, Keir E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145518/ https://www.ncbi.nlm.nih.gov/pubmed/30263057 http://dx.doi.org/10.3332/ecancer.2018.866 |
Ejemplares similares
-
A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer
por: Cameron, Simon J. S., et al.
Publicado: (2017) -
Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity
por: Cameron, Simon J. S., et al.
Publicado: (2016) -
Antioxidants: The new frontier for translational research in cerebroprotection
por: Tewari, Anurag, et al.
Publicado: (2014) -
Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum
por: Lewis, Paul D, et al.
Publicado: (2010) -
The Gut Microbiome: a New Frontier in Musculoskeletal Research
por: Li, R., et al.
Publicado: (2021)